Sheng-Bin Peng

Sheng-Bin Peng

UNVERIFIED PROFILE

Are you Sheng-Bin Peng?   Register this Author

Register author
Sheng-Bin Peng

Sheng-Bin Peng

Publications by authors named "Sheng-Bin Peng"

Are you Sheng-Bin Peng?   Register this Author

26Publications

1053Reads

31Profile Views

Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor.

ACS Med Chem Lett 2018 Jun 21;9(6):557-562. Epub 2018 May 21.

Discovery Chemistry Research and Technologies and Oncology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsmedchemlett.8b00110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004567PMC
June 2018

Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers.

Pharmacol Ther 2015 May 27;149:139-49. Epub 2014 Dec 27.

Oncology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2014.12.003DOI Listing
May 2015

The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation.

Mol Cancer Ther 2014 Oct 13;13(10):2253-63. Epub 2014 Aug 13.

Oncology Discovery Research, Lilly Research Laboratories, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0257DOI Listing
October 2014

A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models.

Mol Cancer Ther 2011 Nov 7;10(11):2200-10. Epub 2011 Sep 7.

Cancer Research, DC0434, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-0306DOI Listing
November 2011

Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.

FEBS J 2008 Nov 13;275(21):5258-71. Epub 2008 Sep 13.

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285-0434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1742-4658.2008.06652.xDOI Listing
November 2008

Rapid and recurrent neutrophil mobilization regulated by T134, a CXCR4 peptide antagonist.

Exp Hematol 2008 Sep 20;36(9):1098-109. Epub 2008 May 20.

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0301472X0800154
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2008.03.021DOI Listing
September 2008

Identification and expression of novel isoforms of human stromal cell-derived factor 1.

Gene 2006 Jun 19;374:174-9. Epub 2006 Apr 19.

Cardiovascular Division, Lilly Research Laboratories, Eli Lilly and Company, DC0434, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2006.02.001DOI Listing
June 2006

Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Int J Oncol 2005 Nov;27(5):1329-39

Integrative Biology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
November 2005

In vitro and in vivo self-cleavage of Streptococcus pneumoniae signal peptidase I.

Eur J Biochem 2002 Aug;269(16):3969-77

Infectious Diseases Research, Lilly Research Laboratories, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1432-1033.2002.03083.xDOI Listing
August 2002

Identification and characterization of Streptococcus pneumoniae Ffh, a homologue of SRP54 subunit of mammalian signal recognition particle.

Biochem Biophys Res Commun 2002 Apr;292(3):601-8

Infectious Diseases Research, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/bbrc.2002.6694DOI Listing
April 2002